Nitric oxide inhibits serotonin-induced calcium release in pulmonary artery smooth muscle cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 272, Issue 1 16-1, 1997, Pages

  Yuan, Xiao Jian ^a   Bright, Rose T ^a   Aldinger, Ann M ^a   Rubin, Lewis J ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

caffeine; calcium oscillation; cyclopiazonic acid; inositol 1,4,5 trisphosphate sensitive calcium store

Indexed keywords

CAFFEINE; CYCLOPIAZONIC ACID; INOSITOL 1,4,5 TRISPHOSPHATE; NITRIC OXIDE;

ANIMAL CELL; ARTERY MUSCLE; ARTICLE; BLOOD VESSEL REACTIVITY; CALCIUM TRANSPORT; CELL MEMBRANE PERMEABILITY; ENZYME ACTIVATION; EXTRACELLULAR CALCIUM; LUNG CIRCULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PULMONARY ARTERY; RAT; SARCOPLASMIC RETICULUM; SMOOTH MUSCLE FIBER;

EID: 0031035835     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1997.272.1.l44     Document Type: Article

References (33)

1. Archer, S. L., J. M. C. Huang, V. Hampl. D. P. Nelson, P. J. Shultz, and E. K. Weir. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA 91: 7583-7587, 1994.
2. Arnold, W. P., C. K. Mittal, S. Katsuki, and F. Murad. Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proc. Natl. Acad. Sci. USA 74: 3203-3207, 1977.
3. i in vascular smooth muscle by inhibition of the calcium current. Cell Calcium 15: 122-131, 1995.
4. Bolotina, V. M., S. Najibi, J. J. Palacino, P. J. Pagano, and R. A. Cohen. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature Lond. 368: 850-853, 1994.
5. Clapp, L. H., and A. M. Gurney. Modulation of calcium movements by nitroprusside in isolated vascular smooth muscle cells. Pfluegers Arch. 418: 462-470, 1991.
6. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 4401-4450, 1985.
7. Hevel, J. M., and M. A. Marletta. Nitric-oxide synthase assays. In: Methods in Enzymology, edited by L. Parker. New York: Academic, 1994, vol. 233, p. 250-258.
8. Ignarro, L. J., T. M. Burke, K. S. Wood M. S. Wolin, and P. J. Kadowitz. Association between cyclic GMP accumulation and acetylcholine-elicited relaxation of bovine intrapulmonary artery. J. Pharmacol. Exp. Ther. 228: 682-690, 1984.
9. Ignarro, L. J., R. E. Byrns, G. M. Buga, and K. S. Wood. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ. Res. 61: 866-879, 1987.
10. 2+ transport ATPases. J. Membr. Biol. 141: 1-6, 1994.
11. 2+ channels by cAMP and cGMP in vascular smooth muscle cells. Circ. Res. 73: 1128-1137, 1993.
12. Kinsella, J. P., S. R. Neish, E. Shaffer, and S. H. Abman. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340: 819-820, 1992.
13. 2+ oscillations. Am. J. Physiol. 269 (Cell Physiol. 38): C1079-C1092, 1995.
14. Madden, J. A., M. S. Vadula, and V. P. Kurup. Effects of hypoxia and other vasoactive agents on pulmonary and cerebral artery smooth muscle cells. Am. J. Physiol. 263 (Lung Cell. Mol. Physiol. 7): L384-L393, 1992.
15. McMahon, T. J., J. S. Hood, B. D. Nossaman, and P. J. Kadowitz. Analysis of responses to serotonin in the pulmonary vascular bed of the cat. J. Appl. Physiol. 75: 93-102, 1993.
16. Milbourne, E. A., and F. L. Bygrave. Do nitric oxide and cGMP play a role in calcium cycling? Cell Calcium 18: 207-213, 1995.
17. Murakawa, T., B. T. Altura, A. Carella, and B. M. Altura. Importance of magnesium and potassium concentration on basal tone and 5-HT-induced contractions in canine isolated coronary artery. Br. J. Pharmacol. 94: 325-334, 1988.
18. Palmer, R. M. J., D. S. Ashton, and S. Moncada. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature Lond. 333: 664-666, 1988.
19. Palmer, R. M. J., A. G. Ferrige, and S. Moncada. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature Lond. 327: 524-526, 1987.
20. Pepke-Zaba, J., T. W. Higenbottam, A. T. Dinh-Xuan, A. Stone, and J. Wallwork. Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet 338: 1173-1174, 1991.
21. 2+influx. Nature Lond. 364: 809-814, 1993.
22. 2+-ATPase by cGMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA 84: 5685-5689, 1987.
23. Somlyo, A. P., and A. V. Somlyo. Signal transduction and regulation in smooth muscle Nature Lond. 372: 231-236, 1994.
24. Tare, M., H. C. Parkington, H. A. Coleman, T. O. Neild, and G. J. Dusting. Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium. Nature Lond. 346: 69-71, 1990.
25. 2+ stores are revealed in cultured vascular smooth muscle cells. Proc. Natl. Acad. Sci. USA 91: 5908-5912, 1994.
26. 2+ by sarcoplasmic reticulum in vascular smooth muscle. Circ. Res. 62: 961-964, 1988.
27. 2+ channels in the plasma membrane of cultured vascular endothelial cells. Am. J. Physiol. 269 (Cell Physiol. 38): C733-C738, 1995.
28. 2+ in pulmonary and cerebral arterial myocytes. Am. J. Physiol. 265 (Lung Cell. Mol. Physiol. 9): L591-L597, 1993.
29. i smooth muscle. Annu. Rev. Physiol. 51: 315-329, 1989.
30. 2+ pump of smooth muscle via phosphorylation of phosphatidylinositol. Biochem. J. 255: 855-863, 1988.
31. i in pulmonary arterial myocytes. Circ. Res. 77: 370-378, 1995.
32. + channels. Proc. Natl. Acad. Sci. USA 93: 10489-10494, 1996.
33. Zapol, W. M., S. Rimar, N. Gillis, M. Marietta, and C. W. Bosken. Nitric oxide and the lung. Am. J. Respir. Crit. Care Med. 149: 1375-1380, 1994.